Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Search for other papers by Heleen I Jansen in
Google Scholar
PubMed
Search for other papers by Marijn M Bult in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Endocrinology and Metabolism, Amsterdam, The Netherlands
Search for other papers by Peter H Bisschop in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Search for other papers by Jacquelien J Hillebrand in
Google Scholar
PubMed
the measurement of serum thyroid-stimulating hormone (TSH) concentration, possibly followed up with serum free thyroxine (fT4) concentration when TSH is above or below the reference interval. Once a thyroid disorder is diagnosed and treatment is
Search for other papers by Mírian Romitti in
Google Scholar
PubMed
Search for other papers by Vitor C Fabris in
Google Scholar
PubMed
Search for other papers by Patricia K Ziegelmann in
Google Scholar
PubMed
Search for other papers by Ana Luiza Maia in
Google Scholar
PubMed
Search for other papers by Poli Mara Spritzer in
Google Scholar
PubMed
serum levels of thyroid-stimulating hormone (TSH). The Newcastle–Ottawa Scale (NOS) (Retrieved August, 2017, from: www.ohri.ca/programs/clinical_epidemiology/oxford.asp) was used to assess the quality of the studies included in the meta-analysis. The
Endocrinology & Diabetes, Salford Royal NHS Foundation Trust, Salford, UK
Search for other papers by Lauren Bell in
Google Scholar
PubMed
Endocrinology & Diabetes, Salford Royal NHS Foundation Trust, Salford, UK
Search for other papers by Ann Louise Hunter in
Google Scholar
PubMed
CEDM Centre of Endocrinology, Diabetes & Metabolism, Limassol, Cyprus
Search for other papers by Angelos Kyriacou in
Google Scholar
PubMed
Endocrinology & Diabetes, Salford Royal NHS Foundation Trust, Salford, UK
Search for other papers by Annice Mukherjee in
Google Scholar
PubMed
Endocrinology & Diabetes, Salford Royal NHS Foundation Trust, Salford, UK
Search for other papers by Akheel A Syed in
Google Scholar
PubMed
gonadotrophin (hCG) ( 4 ), and TSH-producing pituitary adenomas. Graves’ disease, the commonest cause of hyperthyroidism, has an annual incidence of 20–50 per 100,000 population, a peak incidence between 30 and 50 years of age, and a lifetime risk of 3% for
Search for other papers by Qing Zhou in
Google Scholar
PubMed
Search for other papers by Li Yong Zhang in
Google Scholar
PubMed
Search for other papers by Mei Feng Dai in
Google Scholar
PubMed
Search for other papers by Zhen Li in
Google Scholar
PubMed
Search for other papers by Chao Chun Zou in
Google Scholar
PubMed
Search for other papers by Hui Liu in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism has been defined as an elevated serum thyroid-stimulating hormone (TSH) with normal free thyroxine levels ( 1 ). Despite maintaining normal thyroid hormone levels, patients with subclinical
Search for other papers by Clara Lundetoft Clausen in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Search for other papers by Trine Holm Johannsen in
Google Scholar
PubMed
Search for other papers by Linda Maria Hilsted in
Google Scholar
PubMed
Search for other papers by Niels Erik Skakkebæk in
Google Scholar
PubMed
Search for other papers by Pal Bela Szecsi in
Google Scholar
PubMed
Search for other papers by Lise Pedersen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Thomas Benfield in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
, 14 , 15 ), and recent studies have reported inverse correlations between thyroid stimulating hormone (TSH) and interleukin 6 (IL-6) in patients with COVID-19 ( 6 , 9 , 16 ). Thus, this study aimed to evaluate thyroid hormone involvement in the
Search for other papers by Aglaia Kyrilli in
Google Scholar
PubMed
Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
Department of Gynecology and Obstetrics, Copenhagen University Hospital (Hvidovre Hospital), Hvidovre, Denmark
Search for other papers by Sofie Bliddal in
Google Scholar
PubMed
Carelink Nærhospital, Roskilde, Denmark
Search for other papers by Dorthe Hansen Precht in
Google Scholar
PubMed
Institute of Clinical Medicine, Faculty of Health and Clinical Research, Copenhagen University, Copenhagen, Denmark
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Université Libre de Bruxelles (ULB), Brussels, Belgium
Search for other papers by Kris Poppe in
Google Scholar
PubMed
, 16 ). Current guidelines from the American Thyroid Association (published in 2017) recommend that TPOAb-positive euthyroid pregnant women should have measurements of serum thyroid-stimulating hormone (TSH) every 4 weeks through the late 2nd
Search for other papers by Boni Xiang in
Google Scholar
PubMed
Search for other papers by Ran Tao in
Google Scholar
PubMed
Search for other papers by Xinhua Liu in
Google Scholar
PubMed
Search for other papers by Xiaoming Zhu in
Google Scholar
PubMed
Search for other papers by Min He in
Google Scholar
PubMed
Search for other papers by Zengyi Ma in
Google Scholar
PubMed
Search for other papers by Yehong Yang in
Google Scholar
PubMed
Search for other papers by Zhaoyun Zhang in
Google Scholar
PubMed
Search for other papers by Yiming Li in
Google Scholar
PubMed
Search for other papers by Zhenwei Yao in
Google Scholar
PubMed
Search for other papers by Yongfei Wang in
Google Scholar
PubMed
Search for other papers by Hongying Ye in
Google Scholar
PubMed
decreased iodine-131 (I 131 ) accumulation in the thyroid of euthyroid patients ( 3 ). Dexamethasone administration (16 mg daily for 2.5 days) was reported to reduce the thyroid-stimulating hormone (TSH) and free T3 (FT3) secretion and blunted the TSH
Search for other papers by Giorgio Radetti in
Google Scholar
PubMed
Search for other papers by Mariacarolina Salerno in
Google Scholar
PubMed
Search for other papers by Chiara Guzzetti in
Google Scholar
PubMed
Search for other papers by Marco Cappa in
Google Scholar
PubMed
Search for other papers by Andrea Corrias in
Google Scholar
PubMed
Search for other papers by Alessandra Cassio in
Google Scholar
PubMed
Search for other papers by Graziano Cesaretti in
Google Scholar
PubMed
Search for other papers by Roberto Gastaldi in
Google Scholar
PubMed
Search for other papers by Mario Rotondi in
Google Scholar
PubMed
Search for other papers by Fiorenzo Lupi in
Google Scholar
PubMed
Search for other papers by Antonio Fanolla in
Google Scholar
PubMed
Search for other papers by Giovanna Weber in
Google Scholar
PubMed
Search for other papers by Sandro Loche in
Google Scholar
PubMed
started in patients with either subclinical (high TSH with normal fT4) or overt hypothyroidism (subnormal fT4 and increased TSH). There is no consensus on the timing to start or discontinue therapy based on TSH concentrations in children and adolescents
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
Search for other papers by Biagio Cangiano in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
Search for other papers by Marco Bonomi in
Google Scholar
PubMed
Introduction Central hypothyroidism (CeH) is a rare and heterogenous hypothyroid condition resulting from an insufficient stimulation of an otherwise normal thyroid gland by the hypophyseal thyrotropin hormone (TSH). This loss of central
Search for other papers by Bogumila Urgatz in
Google Scholar
PubMed
Search for other papers by Kris G Poppe in
Google Scholar
PubMed
of TH at this time. The increase in TH occurs due to a mild activation of the TSH receptor by hCG (which bears structural similarities to TSH), resulting in increased levels of T3 and T4, and a consequent modest fall in TSH ( 2 , 3 , 4 ). Increasing